Pharmaceutical Executive-07-03-2007

Column
Pharmaceutical Executive

July 03, 2007

All hell broke loose on May 21 when the New England Journal of Medicine released Cleveland Clinic cardiologist Dr. Steven Nissen's meta-analysis of 42 studies of Avandia, showing a 43 percent increased risk of heart attack.

Pharmaceutical Executive
From the Editor

July 03, 2007

The Acomplia story isn't ending. It's just beginning. Get ready to see what happens when a much-desired drug is marketed by people accountable to no one.

Pharmaceutical Executive
Toolkit

July 03, 2007

Personalized health communication enables marketers to vary the messages they deliver, and it increases their ability to motivate different patients to act

Pharmaceutical Executive
Features

July 03, 2007

Although pricey, serialization with RFID is expected to reduce logistical errors and address some aspects of supply chain security

Pharmaceutical Executive

If pharma is seen as a genuine contributor to the policy debate on comparative effectiveness, it could influence funding, pricing, and coverage decisions

Pharmaceutical Executive
Global Report

July 03, 2007

Says Roche UK CEO John Melville: "There is little difference in the incidence of cancer, in broad terms, across Europe, but cancer survival is very different"

Pharmaceutical Executive

Though it may sound paradoxical, the most effective deployment of a patient-feedback program is within a pharmaceutical brand's professional promotions

Pharmaceutical Executive
Features

July 03, 2007

It's bittersweet being one of the leaders of an industry that is not sustainable," a top pharma CEO recently told Carolyn Buck Luce, Ernst & Young's global pharmaceutical sector leader. Bittersweet is a poignant word for a hard-driving exec to issue.

Pharmaceutical Executive
Thought Leader

July 03, 2007

We'll see a more coordinated, worldwide platform not just for marketing, but for R&D and regulatory because of the harmonization that is slowly coming, primarily between Japan, Europe, and the United States

Pharmaceutical Executive
Features

July 03, 2007

What's old and established is in, what's new-and once interpreted as"better"-is out

Pharmaceutical Executive
Column

July 03, 2007

With gaming technology, pharmaceutical companies can display immersive 3-D animation that allows doctors to explore inside an interactive environment pertaining to a drug's method of action

Pharmaceutical Executive
Column

July 03, 2007

Between the constant push for more government regulation of drug marketing and the conservative nature of the industry, the fast-paced world of pharmaceutical advertising doesn't seem too glamorous. But for one night every year, dozens of agencies and pharma companies take a walk down the red carpet to honor their peers at the annual PhAME Awards. Pharm Exec talked to some of the winners and industry insiders to take the current pulse of consumer advertising and find out what it takes to make an award-winning DTC ad.